Evaluating an Expressive Writing Intervention About Communicatively-Restricted Organizational Stressors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project evaluates the effectiveness of an intervention sought to reduce the physical effects of stress related to those issues that individuals cannot successfully communicate with anyone about. To do this, the investigators will be implementing a writing intervention over the course of the 6-week study. The investigators will be asking all participants to complete questionnaires over the course of the study period. The investigators are also asking participants to provide a small blood sample (from a fingerstick procedure) at two times during the study as well as saliva samples during that same time. The primary research question asks if this intervention procedure is effective. The investigators are evaluating total cholesterol, high sensitivity c-reactive protein, and cortisol.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Expressive Writing on Stress and Work-Related Outcomes Among Student Nurse Interns

NCT06238141

Stress, Psychological

COMPLETED NA

The Effects of Expressive Writing and Compassionate Letter Writing on Emotional Distress Intolerance

NCT05284578

Distress Intolerance

COMPLETED NA

The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor

NCT02848014

Healthy Participants

COMPLETED NA

Using Affectionate Communication as a Response to Acute Stress

NCT00468572

Stress

COMPLETED NA

Internet-based Stress Reduction Training for Students

NCT02062762

Depression Stress

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Expressive Writing

Affectionate Writing Intervention for 20 minutes per day, 2 times per week, 6 weeks.

Group Type EXPERIMENTAL

Expressive Writing

Intervention Type OTHER

Writing intervention for cognitive appraisal of stressor.

No writing

Control Group -- No writing

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Expressive Writing

Writing intervention for cognitive appraisal of stressor.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 110 pounds in weight
* Ability to fast for 8 hours prior to laboratory visit
* Staff member at Santa Clara University
* Certain level of inclusionary pretest stress measure

Exclusion Criteria

* Hepatitis
* Endocrine Disease
* Kidney or Liver Disease
* Cancer (in any form)
* Cushing's disorder
* Rheumatological disorders
* Respiratory Disorders
* Diabetes
* High blood pressure
* Low blood pressure
* Heart or cardiovascular problems
* Chemotherapy
* Current use of alpha or beta blockers, steroids, or hormone replacements
* Pregnant and/or breastfeeding mothers

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes